Stem cells as biological heart pacemakers

Expert Opinion on Biological Therapy

Volumn 5, Issue 12, 2005, Pages 1531-1537

  Gepstein, Lior ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Arrhythmia therapy; Biological pacemakers; Bradyarrhythmias; Cell therapy; Gene therapy; Ionic channels; Stem cells

Indexed keywords

ION CHANNEL;

ADOPTIVE IMMUNOTHERAPY; BIOLOGICAL THERAPY; BRADYCARDIA; CELL DIFFERENTIATION; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; GENE THERAPY; GENETIC ENGINEERING; HEART ARRHYTHMIA; HEART CONDUCTION; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART RATE; HUMAN; IMPLANT; ION CURRENT; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PHENOTYPE; REVIEW; SINUS NODE; STEM CELL TRANSPLANTATION; TISSUE ENGINEERING;

BIOLOGICAL CLOCKS; GENE THERAPY; HEART; HEART DISEASES; HUMANS; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 28844472971     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.5.12.1531     Document Type: Review

References (37)

1. SCHRAM G, POURRIER M, MELNYK P, NATTEL S: Differential distribution of cardiac ion channel expression as a basis for regional specialization in electrical function. Circ. Res. (2002) 90:939-950.
2. KUSUMOTO FM, GOLDSCHLAGER N: Cardiac pacing. N. Engl. J. Med. (1996) 334:89-97.
3. LECLERCQ C, HARE JM: Ventricular resynchronization: current state of the art. Circulation (2004) 109:296-299.
4. ROSEN MR, BRINK PR, COHEN IS, ROBINSON RB: Genes, stem cells and biological pacemakers. Cardiovasc. Res. (2004) 64:12-23.
5. ROSEN MR: 15th annual Gordon K. Moe Lecture. Biological pacemaking: in our lifetime? Heart Rhythm (2005) 2:418-428.
6. ISNER JM: Myocardial gene therapy. Nature (2002) 415:234-239.
7. HAJJAR RJ, DEL MONTE F, MATSUI T, ROSENZWEIG A: Prospects for gene therapy for heart failure. Circ. Res. (2000) 86:616-621.
8. REINLIB L, FIELD L: Cell transplantation as future therapy for cardiovascular disease?: A workshop of the National Heart, Lung, and Blood Institute. Circulation (2000) 101:E182-E187.
9. TOMASELLI GF, DONAHUE JK: Somatic gene transfer and cardiac arrhythmias: problems and prospects. J. Cardiovasc. Electrophysiol. (2003) 14:547-550.
10. GEPSTEIN L, FELD Y, YANKELSON L: Somatic gene and cell therapy strategies for the treatment of cardiac arrhythmias. Am. J. Physiol. Heart Circ. Physiol. (2004) 286:H815-H22.
11. EDELBERG JM, AIRD WC, ROSENBERG RD: Enhancement of murine cardiac chronotropy by the molecular transfer of the human beta2 adrenergic receptor cDNA. J. Clin. Invest. (1998) 101:337-343.
12. EDELBERG JM, HUANG DT, JOSEPHSON ME, ROSENBERG RD: Molecular enhancement of porcine cardiac chronotropy. Heart (2001) 86:559-562.
13. MIAKE J, MARBAN E, NUSS HB: Biological pacemaker created by gene transfer. Nature (2002) 419:132-133.
14. KUBO Y, BALDWIN TJ, JAN YN, JAN LY: Primary structure and functional expression of a mouse inward rectifier potassium channel. Nature (1993) 362:127-133.
15. LUDWIG A, ZONG X, JEGLITSCH M, HOFMANN F, BIEL M: A family of hyperpolarization-activated mammalian cation channels. Nature (1998) 393:587-591.
16. QU J, PLOTNIKOV AN, DANILO P JR et al.: Expression and function of a biological pacemaker in canine heart. Circulation (2003) 107:1106-1109.
17. PLOTNIKOV AN, SOSUNOV EA, QU J et al.; Biological pacemaker implanted in canine left bundle branch provides ventricular escape rhythms that have physiologically acceptable rates. Circulation (2004) 109:506-512.
18. MIAKE J, MARBAN E, NUSS HB: Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative suppression. J. Clin. Invest. (2003) 111:1529-1536.
19. MULLER-EHMSEN J, WHITTAKER P, KLONER RA et al.: Survival and development of neonatal rat cardiomyocytes transplanted into adult myocardium. J. Mol. Cell. Cardiol. (2002) 34:107-116.
20. VALIUNAS V, DORONIN S, VALIUNIENE L et al.: Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. J. Physiol. (2004) 555:617-626.
21. POTAPOVA I, PLOTNIKOV A, LU Z et al.: Human mesenchymal stem cells as a gene delivery system to create cardiac pacemakers. Circ. Res. (2004) 94:952-959.
22. FELD Y, MELAMED-FRANK M, KEHAT I et al.: Electrophysiological modulation of cardiomyocytic tissue by transfected fibroblasts expressing potassium channels: a novel strategy to manipulate excitability. Circulation (2002) 105:522-529.
23. GEPSTEIN L: Derivation and potential applications of human embryonic stem cells. Circ. Res. (2002) 91:866-876.
24. EVANS MJ, KAUFMAN MH: Establishment in culture of pluripotential cells from mouse embryos. Nature (1981) 292:154-156.
25. MARTIN G: Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl Acad. Sci. USA (1981) 78:7635.
26. THOMSON JA, ITSKOVITZ-ELDOR J, SHAPIRO SS et al.: Embryonic stem cell lines derived from human blastocysts. Science (1998) 282:1145-1147.
27. REUBINOFF BE, PERA MF, FONG CY, TROUNSON A, BONGSO A: Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat. Biotechnol. (2000) 18:399-404.
28. KEHAT I, KENYAGIN-KARSENTI D, SNIR M et al.: Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. (2001) 108:407-414.
29. HE JQ, MA Y, LEE Y, THOMSON JA, KAMP TJ: Human embryonic stem cells develop into multiple types of cardiac myocytes: action potential characterization. Circ. Res. (2003) 93:32-39.
30. MUMMERY C, WARD-VAN OOSTWAARD D, DOEVENDANS P et al.: Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells. Circulation (2003) 107:2733-2740.
31. XU C, POLICE S, RAO N, CARPENTER MK: Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circ. Res. (2002) 91:501-508.
32. PASSIER R, OOSTWAARD DW, SNAPPER J et al.: Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells (2005) 23:772-780.
33. SATIN J, KEHAT I, CASPI O et al.: Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J. Physiol. (2004) 559:479-496.
34. REPPEL M, BOETTINGER C, HESCHELER J: Beta-adrenergic and muscarinic modulation of human embryonic stem cell-derived cardiomyocytes. Cell. Physiol. Biochem. (2004) 14:187-196.
35. KEHAT I, GEPSTEIN A, SPIRA A, ITSKOVITZ-ELDOR J, GEPSTEIN L: High-resolution electrophysiological assessment of human embryonic stem cell-derived cardiomyocytes: a novel in vitro model for the study of conduction. Circ. Res. (2002) 91:659-661.
36. KEHAT I, KHIMOVICH L, CASPI O et al.: Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat. Biotechnol. (2004) 22:1282-1289.
37. XUE T, CHO HC, AKAR FG et al.: Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers. Circulation (2005) 111:11-20.